Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

The human secretome.

Uhlén M, Karlsson MJ, Hober A, Svensson AS, Scheffel J, Kotol D, Zhong W, Tebani A, Strandberg L, Edfors F, Sjöstedt E, Mulder J, Mardinoglu A, Berling A, Ekblad S, Dannemeyer M, Kanje S, Rockberg J, Lundqvist M, Malm M, Volk AL, Nilsson P, Månberg A, Dodig-Crnkovic T, Pin E, Zwahlen M, Oksvold P, von Feilitzen K, Häussler RS, Hong MG, Lindskog C, Ponten F, Katona B, Vuu J, Lindström E, Nielsen J, Robinson J, Ayoglu B, Mahdessian D, Sullivan D, Thul P, Danielsson F, Stadler C, Lundberg E, Bergström G, Gummesson A, Voldborg BG, Tegel H, Hober S, Forsström B, Schwenk JM, Fagerberg L, Sivertsson Å.

Sci Signal. 2019 Nov 26;12(609). pii: eaaz0274. doi: 10.1126/scisignal.aaz0274.

PMID:
31772123
2.

Development of Ionic Liquid-Water-Based Thermomorphic Solvent (TMS)-Systems for Biocatalytic Reactions.

Meyer LE, Gummesson A, Kragl U, von Langermann J.

Biotechnol J. 2019 Oct;14(10):e1900215. doi: 10.1002/biot.201900215. Epub 2019 Jul 5.

PMID:
31166077
3.

Research participants' preferences for receiving genetic risk information: a discrete choice experiment.

Viberg Johansson J, Langenskiöld S, Segerdahl P, Hansson MG, Hösterey UU, Gummesson A, Veldwijk J.

Genet Med. 2019 Oct;21(10):2381-2389. doi: 10.1038/s41436-019-0511-4. Epub 2019 Apr 17.

PMID:
30992550
4.

Individual and stable autoantibody repertoires in healthy individuals.

Neiman M, Hellström C, Just D, Mattsson C, Fagerberg L, Schuppe-Koistinen I, Gummesson A, Bergström G, Kallioniemi O, Achour A, Sallinen R, Uhlén M, Nilsson P.

Autoimmunity. 2019 Feb;52(1):1-11. doi: 10.1080/08916934.2019.1581774. Epub 2019 Mar 5.

PMID:
30835561
5.

Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects.

Gummesson A, Strömberg U, Schmidt C, Kullberg J, Angerås O, Lindgren S, Hjelmgren O, Torén K, Rosengren A, Fagerberg B, Brandberg J, Bergström G.

PLoS One. 2018 Aug 22;13(8):e0202666. doi: 10.1371/journal.pone.0202666. eCollection 2018.

6.

A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor.

Stanne TM, Olsson M, Lorentzen E, Pedersen A, Gummesson A, Gils A, Jood K, Engström G, Melander O, Declerck PJ, Jern C.

Thromb Haemost. 2018 Feb;118(2):298-308. doi: 10.1160/TH17-04-0249. Epub 2018 Jan 29.

7.

Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes.

Gummesson A, Nyman E, Knutsson M, Karpefors M.

Diabetes Obes Metab. 2017 Sep;19(9):1295-1305. doi: 10.1111/dom.12971. Epub 2017 May 22. Review.

PMID:
28417575
8.

Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult Chinese subjects.

Gummesson A, Li H, Gillen M, Xu J, Niazi M, Hirshberg B.

Clin Drug Investig. 2014 Nov;34(11):763-72. doi: 10.1007/s40261-014-0230-1.

PMID:
25269885
9.

Volatile organic compounds produced by the phytopathogenic bacterium Xanthomonas campestris pv. vesicatoria 85-10.

Weise T, Kai M, Gummesson A, Troeger A, von Reuß S, Piepenborn S, Kosterka F, Sklorz M, Zimmermann R, Francke W, Piechulla B.

Beilstein J Org Chem. 2012;8:579-96. doi: 10.3762/bjoc.8.65. Epub 2012 Apr 17.

10.

Role of the gut in visceral fat inflammation and metabolic disorders.

Lam YY, Mitchell AJ, Holmes AJ, Denyer GS, Gummesson A, Caterson ID, Hunt NH, Storlien LH.

Obesity (Silver Spring). 2011 Nov;19(11):2113-20. doi: 10.1038/oby.2011.68. Epub 2011 Sep 1. Review. No abstract available.

11.

Intestinal permeability is associated with visceral adiposity in healthy women.

Gummesson A, Carlsson LM, Storlien LH, Bäckhed F, Lundin P, Löfgren L, Stenlöf K, Lam YY, Fagerberg B, Carlsson B.

Obesity (Silver Spring). 2011 Nov;19(11):2280-2. doi: 10.1038/oby.2011.251. Epub 2011 Aug 18.

12.

Identification of adipocyte genes regulated by caloric intake.

Franck N, Gummesson A, Jernås M, Glad C, Svensson PA, Guillot G, Rudemo M, Nyström FH, Carlsson LM, Olsson B.

J Clin Endocrinol Metab. 2011 Feb;96(2):E413-8. doi: 10.1210/jc.2009-2534. Epub 2010 Nov 3.

PMID:
21047925
13.

Changes in human adipose tissue gene expression during diet-induced weight loss.

Svensson PA, Gummesson A, Carlsson LMS, Sjöholm K.

World Rev Nutr Diet. 2010;101:103-114. doi: 10.1159/000314515. Epub 2010 Apr 30. Review. No abstract available.

14.

Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis.

Karlsson C, Jernås M, Olsson B, Lystig T, Gummesson A, Storlien L, Groop L, Carlsson B.

Diabetes Res Clin Pract. 2010 Jun;88(3):252-8. doi: 10.1016/j.diabres.2010.03.009. Epub 2010 Apr 8.

PMID:
20381186
15.

Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids.

Olofsson LE, Olsson B, Lystig T, Jacobson P, Jernås M, Sjöholm K, Gummesson A, Sjöström L, Eriksson P, Hamsten A, Hale LP, Thelle DS, Carlsson B, Carlsson LM.

Metabolism. 2010 Sep;59(9):1316-8. doi: 10.1016/j.metabol.2009.12.006. Epub 2010 Jan 12.

PMID:
20070991
16.

Changes in human adipose tissue gene expression during diet-induced weight loss.

Svensson PA, Gummesson A, Carlsson LM, Sjöholm K.

J Nutrigenet Nutrigenomics. 2010;3(4-6):239-50. doi: 10.1159/000324360. Epub 2011 Apr 6. No abstract available.

PMID:
21474955
17.

Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss.

Saiki A, Olsson M, Jernås M, Gummesson A, McTernan PG, Andersson J, Jacobson P, Sjöholm K, Olsson B, Yamamura S, Walley A, Froguel P, Carlsson B, Sjöström L, Svensson PA, Carlsson LM.

J Clin Endocrinol Metab. 2009 Oct;94(10):3987-94. doi: 10.1210/jc.2009-0292. Epub 2009 Jul 14.

PMID:
19602561
18.

Adipose tissue is not an important source for matrix metalloproteinase-9 in the circulation.

Gummesson A, Hagg D, Olson FJ, Hulthe J, Carlsson LM, Fagerberg B.

Scand J Clin Lab Invest. 2009;69(6):636-42. doi: 10.3109/00365510902912747.

PMID:
19575331
19.

Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial.

Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, Bengtsson C, Bouchard C, Carlsson B, Dahlgren S, Jacobson P, Karason K, Karlsson J, Larsson B, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Carlsson LM; Swedish Obese Subjects Study.

Lancet Oncol. 2009 Jul;10(7):653-62. doi: 10.1016/S1470-2045(09)70159-7. Epub 2009 Jun 24.

PMID:
19556163
20.

Regulation of the fibrosis and angiogenesis promoter SPARC/osteonectin in human adipose tissue by weight change, leptin, insulin, and glucose.

Kos K, Wong S, Tan B, Gummesson A, Jernas M, Franck N, Kerrigan D, Nystrom FH, Carlsson LM, Randeva HS, Pinkney JH, Wilding JP.

Diabetes. 2009 Aug;58(8):1780-8. doi: 10.2337/db09-0211. Epub 2009 Jun 9.

21.

Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism.

Magnusson B, Gummesson A, Glad CA, Goedecke JH, Jernås M, Lystig TC, Carlsson B, Fagerberg B, Carlsson LM, Svensson PA.

Metabolism. 2008 Sep;57(9):1307-13. doi: 10.1016/j.metabol.2008.04.028.

PMID:
18702959
22.

Regulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissue.

Svensson PA, Gabrielsson BG, Jernås M, Gummesson A, Sjöholm K.

Cell Mol Biol Lett. 2008;13(4):599-613. doi: 10.2478/s11658-008-0025-6. Epub 2008 Jul 18.

23.

Circulating matrix metalloproteinase 9 levels in relation to sampling methods, femoral and carotid atherosclerosis.

Olson FJ, Schmidt C, Gummesson A, Sigurdardottir V, Hulthe J, Wiklund O, Fagerberg B.

J Intern Med. 2008 Jun;263(6):626-35. doi: 10.1111/j.1365-2796.2008.01927.x. Epub 2008 Mar 12.

24.

Relations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies.

Gummesson A, Jernås M, Svensson PA, Larsson I, Glad CA, Schéle E, Gripeteg L, Sjöholm K, Lystig TC, Sjöström L, Carlsson B, Fagerberg B, Carlsson LM.

J Clin Endocrinol Metab. 2007 Dec;92(12):4759-65. Epub 2007 Sep 25.

PMID:
17895319
25.

Effects of bariatric surgery on mortality in Swedish obese subjects.

Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study.

N Engl J Med. 2007 Aug 23;357(8):741-52.

26.

Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome.

Behre CJ, Gummesson A, Jernås M, Lystig TC, Fagerberg B, Carlsson B, Carlsson LM.

Metabolism. 2007 Aug;56(8):1022-8.

PMID:
17618945
27.

The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction.

Palming J, Sjöholm K, Jernås M, Lystig TC, Gummesson A, Romeo S, Lönn L, Lönn M, Carlsson B, Carlsson LM.

J Clin Endocrinol Metab. 2007 Jun;92(6):2346-52. Epub 2007 Apr 3.

PMID:
17405841
28.

A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A.

Sjöholm K, Palming J, Olofsson LE, Gummesson A, Svensson PA, Lystig TC, Jennische E, Brandberg J, Torgerson JS, Carlsson B, Carlsson LM.

J Clin Endocrinol Metab. 2005 Apr;90(4):2233-9. Epub 2004 Dec 28.

PMID:
15623807

Supplemental Content

Loading ...
Support Center